caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1619077369

Brian Acker

PRACTICEPIONEER VALLEY RADIATION ONCOLOGY, PCSee all providers at this practice →
SpecialistSpringfield, MAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
58
Beneficiaries
—
Total drug cost
$945
Distinct drugs
2
Brand share
0.0%
Top prescribed drugs
Mometasone Furoate35 claims
Tamsulosin Hcl23 claims
REFERRAL NETWORK

Where Brian Acker's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
BAYSTATE MEDICAL CENTER INC1471,240
Seth Kaufman
Radiation Oncology · Boston, MA
44151
Katarzyna Lameka
Diagnostic Radiology · New York, NY
1228
Wilson Mertens
Hematology-Oncology · Springfield, MA
12102
BAYSTATE MARY LANE HOSPITAL CORPORATION1249
VISITING NURSE ASSOCIATION AND HOSPICE OF WESTERN NEW ENGLAND, INC.1116
BRODER, MARTIN1128
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.